Average Co-Inventor Count = 7.17
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (24 from 2,076 patents)
2. Ortho-mcneil Pharmaceutical Corp. (4 from 363 patents)
3. Janssen Pharmaceutica (1 from 32 patents)
4. Johnson & Johnson Pharmaceutical Research & Development, LLC (1 from 13 patents)
5. Ortho-mcneil Phamraceutical, Inc. (1 from 1 patent)
6. Janssen Pharmaceuticals, Inc. (159 patents)
31 patents:
1. 12378254 - Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
2. 11897900 - Inhibitors of KEAP1-Nrf2 protein-protein interaction
3. 11827638 - Imidazopyrrolopyridine as inhibitors of the JAK family of kinases
4. 11667644 - Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
5. 11427601 - Inhibitors of KEAP1-Nrf2 protein-protein interaction
6. 11254673 - Small molecule inhibitors of NF-κB inducing kinase
7. RE48841 - Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
8. 11059828 - Disubstituted octahydropyrrolo[3,4-C]pyrroles as orexin receptor modulators
9. 10981911 - Imidazopyrrolopyridine as inhibitors of the JAK family of kinases
10. 10947252 - Inhibitors of KEAP1-Nrf2 protein-protein interaction
11. 10172856 - 2,4-diaminopyrimidine derivatives as histamine H4 modulators
12. 9981909 - Serotonin receptor modulators
13. 9695149 - 1,2,6-substituted benzimidazoles as flap modulators
14. 9682971 - 1,2,5-Substituted benzimidazoles as flap modulators
15. 9682972 - 1,2,5-substituted benzimidazoles as flap modulators